FDA — authorised 22 December 1988
- Marketing authorisation holder: QOL MEDCL
- Status: approved
FDA authorised Ethamolin on 22 December 1988
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 22 December 1988.
QOL MEDCL holds the US marketing authorisation.